Hims & Hers Health Inc.(HIMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HIMS Hims & Hers Health Inc.

Market Closed 05-17 16:00:00 EDT

14.57

+0.53

+3.77%

盘后14.58

+0.01+0.07%

19:59 EDT

High14.67	Low14.00	Vol5.44M
Open14.12	D1 Closing14.04	Amplitude4.75%
Mkt Cap3.13B	Tradable Cap2.71B	Total Shares214.79M
T/O78.80M	T/O Rate2.92%	Tradable Shares185.97M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"HIMS","market":"US","secType":"STK","nameCN":"Hims & Hers Health Inc.","latestPrice":14.57,"timestamp":1715976000000,"preClose":14.04,"halted":0,"volume":5436548,"hourTrading":{"tag":"盘后","latestPrice":14.58,"preClose":14.57,"latestTime":"19:59 EDT","volume":62064,"amount":903710.8972,"timestamp":1715990369596},"delay":0,"floatShares":185967850,"shares":214786086,"eps":-0.011146,"marketStatus":"Market Closed","change":0.53,"latestTime":"05-17 16:00:00 EDT","open":14.12,"high":14.67,"low":14.0034,"amount":78801110.549408,"amplitude":0.047479,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.011146,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1716192000000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":14.04,"preHourTrading":{"tag":"盘前","latestPrice":14.07,"preClose":14.04,"latestTime":"09:29 EDT","volume":8403,"amount":118123.248213,"timestamp":1715952594041},"postHourTrading":{"tag":"盘后","latestPrice":14.58,"preClose":14.57,"latestTime":"19:59 EDT","volume":62064,"amount":903710.8972,"timestamp":1715990369596},"volumeRatio":0.8602286932369984,"optionData":{"bulkOrders":[{"symbol":"HIMS","call":true,"expireDate":1737090000000,"strike":"20.0","timestamp":1715965030606,"price":1.3,"volume":2133,"amount":277290,"type":"-"},{"symbol":"HIMS","call":true,"expireDate":1737090000000,"strike":"20.0","timestamp":1715965030606,"price":1.3,"volume":1534,"amount":199420,"type":"-"}]},"overnightSupported":true},"requestUrl":"/m/hq/s/HIMS/tweets","defaultTab":"tweets","newsList":[{"id":"2435609115","title":"Thermo Fisher (TMO) Unveils New Extended Blood Genotyping Array","url":"https://stock-news.laohu8.com/highlight/detail?id=2435609115","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2435609115?lang=en_us&edition=fundamental","pubTime":"2024-05-16 20:49","pubTimestamp":1715863740,"startTime":"0","endTime":"0","summary":"Thermo Fisher Scientific TMO recently introduced the Applied Biosystems Axiom BloodGenomiX Array and Software, a first-of-its-kind solution for more precise blood genotyping in clinical research. The new array detects most extended and rare blood groups, tissue  and platelet  types in a single, high-throughput assay, supporting future advancements in donor blood matching for extended phenotypes.The latest development is expected to enhance the company’s Life Sciences Solutions segment, which offers advanced microarray solutions for various applications such as predictive genomics, reproductive health and oncology research.For a complete workflow, the BloodGenomiX Array can be coupled with Applied Biosystems BloodGenomiX Reporter Software and the Applied Biosystems GeneTitan MC Instrument, helping alleviate pain points with automated analysis, reporting and quality control. The workflow requires minimal hands-on time and can be run by existing lab staff. According to Thermo Fisher’s vic","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Z2Y2lgbJQfUa74IVYcsxPA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Z2Y2lgbJQfUa74IVYcsxPA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/thermo-fisher-tmo-unveils-extended-124900454.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435606354","title":"Here's Why Investors Should Retain QIAGEN (QGEN) Stock Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2435606354","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2435606354?lang=en_us&edition=fundamental","pubTime":"2024-05-16 20:45","pubTimestamp":1715863500,"startTime":"0","endTime":"0","summary":"QIAGEN N.V. QGEN is likely to grow in the coming quarters, backed by its strong potential in the next-generation sequencing  platform. QIAGEN’s long-term business strategy involves forming partnerships with academic, corporate and other partners for product development, which is very promising. A strong solvency position also buoys optimism.Meanwhile, concerns loom over the impact of macroeconomic challenges on QIAGEN’s operations. Competitive disadvantages may also hurt its performance.In the past year, this Zacks Rank #3  stock has declined 1.2% compared with a 9.4% decrease of the industry. The S&P 500 composite has witnessed a 26.2% rise in the said time frame.The renowned global provider of sample and assay technologies has a market capitalization of $10.36 billion. QIAGEN has an earnings yield of 4.60% compared with the industry’s -25.17%. QGEN’s earnings surpassed estimates in three of the trailing four quarters, delivering an average surprise of 1.7%.Favorable Solvency: QIAGEN ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-investors-retain-qiagen-124500518.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435627475","title":"BRIEF-Hims & Hers Welcomes Anja Manuel To Its Board Of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2435627475","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2435627475?lang=en_us&edition=fundamental","pubTime":"2024-05-16 18:05","pubTimestamp":1715853926,"startTime":"0","endTime":"0","summary":"May 16 (Reuters) - Hims & Hers Health Inc   :   * HIMS & HERS WELCOMES ANJA MANUEL, FOREIGN POLICY EXPERT, DOMESTIC REGULATIONS ADVISOR, AND FORMER DIPLOMAT TO ITS BOARD OF DIRECTORSSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435620779","title":"Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2435620779","media":"Business Wire","top":-1,"share":"https://ttm.financial/m/news/2435620779?lang=en_us&edition=fundamental","pubTime":"2024-05-16 18:00","pubTimestamp":1715853600,"startTime":"0","endTime":"0","summary":"Manuel joins Hims & Hers board of directors to help the company further innovate and increase access to healthcare for millions within the personalized health and wellness space. SAN FRANCISCO, May 16, 2024----Hims & Hers Health, Inc. , the leading health and wellness platform, today announced the appointment of Anja Manuel to the company’s Board of Directors. Ms. Manuel is a co-founder and principal in Rice, Hadley, Gates & Manuel LLC, a strategic consulting firm founded in 2009 that helps U.S. companies navigate international markets and regulatory issues, and a former U.S. government official.In addition to co-leading RHGM LLC, Ms. Manuel is an experienced board member. She currently serves on the board of Ripple Labs, Inc., a privately held leading blockchain payments company, since 2017. She served as a director of Overseas Shipping Group, Inc., a NYSE-listed transportation company, from June 2017 to June 2023, and is a member of several advisory boards of private companies, found","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/pGQk6BjGs1LqneAySCfHSA--~B/aD0yNTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/922bd9605f96d90ba251d1c2b8dfdae6","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/pGQk6BjGs1LqneAySCfHSA--~B/aD0yNTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/922bd9605f96d90ba251d1c2b8dfdae6"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hims-hers-welcomes-anja-manuel-100000619.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435529664","title":"High Insider Ownership Growth Stocks On US Exchange For May 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2435529664","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2435529664?lang=en_us&edition=fundamental","pubTime":"2024-05-16 03:31","pubTimestamp":1715801511,"startTime":"0","endTime":"0","summary":"The United States stock market has shown robust performance recently, with a 1.0% increase over the past week and a significant 27% rise over the last year. In this thriving economic environment, stocks with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the company best.Top 10 Growth Companies With High Insider Ownership In The United States. Overview: Hims & Hers Health, Inc. is a telehealth company providing connections to licensed healthcare professionals across the U.S., the U.K., and other global markets, with a market capitalization of approximately $2.77 billion.Transocean, a company engaged in offshore drilling services, has recently shown signs of operational recovery with a switch from a net loss of US$465 million to a net income of US$98 million in","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/vXkHD.3TwJWHn8.mBhsrQg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/0fc6188304291c4515eba03ba128db49","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/vXkHD.3TwJWHn8.mBhsrQg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/0fc6188304291c4515eba03ba128db49"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/high-insider-ownership-growth-stocks-193151368.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435265153","title":"Here's Why You Should Retain Zimmer Biomet (ZBH) Stock for Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2435265153","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2435265153?lang=en_us&edition=fundamental","pubTime":"2024-05-15 20:59","pubTimestamp":1715777940,"startTime":"0","endTime":"0","summary":"Zimmer Biomet ZBH is well-poised to grow in the coming quarters owing to the encouraging business recovery and increased provider capacity driving backlog pull-through. The company also progresses on the four-pillar strategy to expand the Knee business. Further, the global musculoskeletal market’s gradual stabilization bodes well for its operations.Meanwhile, unfavorable solvency and currency fluctuations raise concerns for Zimmer Biomet.In the past year, this Zacks Rank #3  stock has declined 11% compared with the 2.8% fall of the industryand the 27.1% growth of the S&P 500 composite.The leading musculoskeletal healthcare company has a market capitalization of $24.6 billion. The company has an earnings yield of 6.77% compared to the industry’s 0.2%. Zimmer Biomet surpassed estimates in three of the trailing four quarters and broke even in one, delivering an average earnings surprise of 2.46%.Gradually Stabilizing Market: Despite tough market conditions, the global musculoskeletal mark","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-retain-zimmer-biomet-125900113.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435544351","title":"Boston Scientific (BSX) Gains From MedSurg Growth & Buyouts","url":"https://stock-news.laohu8.com/highlight/detail?id=2435544351","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2435544351?lang=en_us&edition=fundamental","pubTime":"2024-05-15 00:14","pubTimestamp":1715703240,"startTime":"0","endTime":"0","summary":"Boston Scientific BSX is gaining market share across all segments. New regulatory approvals and accretive acquisitions bode well for long-term growth. The stock carries a Zacks Rank #2  currently.Boston Scientific is consistently gaining market share within its MedSurg segment. The Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of gastrointestinal  and pulmonary treatment options. Particularly, the company is gaining market share with its biliary franchise led by the AXIOS Stent and Delivery System and the hemostasis, single-use imaging and metal stents franchises. Within Urology, Boston Scientific continues to expand its market share globally. The company’s stone management franchise is growing well, led by LithoVue Single-Use Digital Flexible Ureteroscope System.Within Neuromodulation, Boston Scientific’s pain business is consistently gaining traction on the strength of spinal cord stimulation , which is driven by its innovative Alpha po","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/OqpBwYnlazUrZRs4ONCSFw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/OqpBwYnlazUrZRs4ONCSFw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/boston-scientific-bsx-gains-medsurg-161400618.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435548123","title":"QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus","url":"https://stock-news.laohu8.com/highlight/detail?id=2435548123","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2435548123?lang=en_us&edition=fundamental","pubTime":"2024-05-14 22:08","pubTimestamp":1715695680,"startTime":"0","endTime":"0","summary":"QIAGEN N.V.QGEN recently secured FDA clearance for the QIAstat-Dx Respiratory Panel Plus syndromic test. Previously authorized under the FDA Emergency Use Authorization  as the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the test is designed to support clinical decision-making in diagnosing upper respiratory infections and covers 21 viral and bacterial targets.The latest development will strongly boost the company’s Molecular Diagnostics business.Respiratory tract infections are the leading cause of emergency department visits and hospitalizations. The CDC estimates that up to 41 million cases of influenza occur each year in the United States, leading to several hundred thousand hospitalizations and up to 51,000 deaths. Against this backdrop, QIAGEN’S new comprehensive diagnostic tool is expected to improve patient care, support responsible antimicrobial stewardship and reduce the burden on healthcare systems.Dx is available in two formats — the QIAstat-Dx Analyzer version, which integrat","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/H9DYdttPy00EKBHhcxtlCA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/H9DYdttPy00EKBHhcxtlCA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qiagen-qgen-wins-fda-nod-140800343.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435257513","title":"Analysts Offer Insights on Healthcare Companies: Avita Medical (RCEL), Inotiv (NOTV) and Hims & Hers Health (HIMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2435257513","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2435257513?lang=en_us&edition=fundamental","pubTime":"2024-05-14 21:01","pubTimestamp":1715691711,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Avita Medical (RCEL – Research Report), Inotiv (NOTV...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-avita-medical-rcel-inotiv-notv-and-hims-hers-health-hims?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-avita-medical-rcel-inotiv-notv-and-hims-hers-health-hims?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2435375839","title":"Teleflex (TFX) Expands Vascular Access Portfolio With New Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2435375839","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2435375839?lang=en_us&edition=fundamental","pubTime":"2024-05-13 19:49","pubTimestamp":1715600940,"startTime":"0","endTime":"0","summary":"Teleflex TFX recently launched the Arrow EZ-IO Intraosseous Access Procedure Tray, which contains all the components required for the IO access procedure. The tray includes the first FDA-cleared sterile, single-use, battery-powered driver, which provides clinicians with an IO access option that can be used in a sterile field in the operation room and any other area of the hospital that requires a sterile field.Enabling a streamlined clinician workflow, the latest development is also expected to enhance the company’s Vascular Access product category.Teleflex’s newest IO access product reflects its commitment to innovation, helping clinicians and elevating patient care in challenging vascular access situations. Delayed vascular access can result in treatment delays, which can lead to adverse outcomes. The Arrow EZ-IO Intraosseous Access System can be used when intravenous access is difficult or impossible to obtain in emergent, urgent or medically necessary cases.Last month, the company ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/H9DYdttPy00EKBHhcxtlCA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/H9DYdttPy00EKBHhcxtlCA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teleflex-tfx-expands-vascular-access-114900454.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435165354","title":"Goldman screens for growth stocks with a near-term path to profitability","url":"https://stock-news.laohu8.com/highlight/detail?id=2435165354","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2435165354?lang=en_us&edition=fundamental","pubTime":"2024-05-13 01:57","pubTimestamp":1715536660,"startTime":"0","endTime":"0","summary":"The drop in valuations of unprofitable growth stocks looks appropriate given the interest rate environment, according to Goldman Sachs. \"One reason unprofitable stocks are sensitive to interest rates ","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/184370489/image_184370489.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/184370489/image_184370489.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4104937-goldman-says-watch-this-unprofitable-growth-stocks-with-rates-set-to-say-high","is_publish_highlight":false,"gpt_icon":1},{"id":"2434854778","title":"5 Medical Info Systems Stocks to Buy for Stable Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2434854778","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2434854778?lang=en_us&edition=fundamental","pubTime":"2024-05-10 20:29","pubTimestamp":1715344140,"startTime":"0","endTime":"0","summary":"The medical info systems industry is thriving due to the growing demand for contactless services. The industry witnessed exponential growth during the pandemic era. Even in the post-pandemic period, remote healthcare, a paperless environment and distant treatment paved the way for digital services.The medical info systems industry comprises companies that develop and market healthcare information systems. These companies offer software and hardware solutions to healthcare providers with secure access to real-time clinical, administrative and financial data in a time-efficient manner.Focus on patient satisfaction, security of patient data and administrative cost control has increased the need for big data, 3D printing, blockchain and artificial intelligence .The Zacks-defined Medical Info Systems Industry is currently in the top 40% of the Zacks Industry Rank. Since it is ranked in the top half of Zacks Ranked Industries, we expect the consulting services industry to outperform the mark","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/cQh8dmZYcaVCEef9kDcJiQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e1e661692a97423f623854b9b5e54b7d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/cQh8dmZYcaVCEef9kDcJiQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e1e661692a97423f623854b9b5e54b7d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/5-medical-systems-stocks-buy-122900544.html","is_publish_highlight":false,"gpt_icon":1},{"id":"2434009651","title":"10 Solid Reasons To Buy Hims & Hers Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2434009651","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2434009651?lang=en_us&edition=fundamental","pubTime":"2024-05-09 19:36","pubTimestamp":1715254602,"startTime":"0","endTime":"0","summary":"It's been a wild week for HIMS stock — CEO Andrew Dudum said a few things that upset investors.H&H also reported blowout earnings, sending shares higher.People quickly forget that H&H is a brilliant c","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1931079143/image_1931079143.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1931079143/image_1931079143.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4691210-10-solid-reasons-to-buy-hims-and-hers-stock-stock","is_publish_highlight":false,"gpt_icon":0},{"id":"2434752093","title":"Results: Hims & Hers Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=2434752093","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2434752093?lang=en_us&edition=fundamental","pubTime":"2024-05-09 18:45","pubTimestamp":1715251558,"startTime":"0","endTime":"0","summary":"Hims & Hers Health, Inc.  just released its first-quarter report and things are looking bullish. It was overall a positive result, with revenues beating expectations by 3.5% to hit US$278m. Hims & Hers Health also reported a statutory profit of US$0.05, which was an impressive 310% above what the analysts had forecast. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Hims & Hers Health's earnings potential next year. Happily, they also upgraded their revenue estimates, and are forecasting them","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/vXkHD.3TwJWHn8.mBhsrQg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/0fc6188304291c4515eba03ba128db49","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/vXkHD.3TwJWHn8.mBhsrQg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/0fc6188304291c4515eba03ba128db49"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/results-hims-hers-health-inc-104558098.html","is_publish_highlight":false,"gpt_icon":1},{"id":"2433875707","title":"Telehealth Stock Gains Popularity With Options Bulls","url":"https://stock-news.laohu8.com/highlight/detail?id=2433875707","media":"Schaeffer's Investment Research","top":-1,"share":"https://ttm.financial/m/news/2433875707?lang=en_us&edition=fundamental","pubTime":"2024-05-07 23:54","pubTimestamp":1715097297,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc stock today, with 33,000 calls exchanged so far -- 8 times the intraday average volume -- compared to 11,000 puts. While the most popular contract is the January 2025 15-strike call, new positions are being opened at the weekly 5/10 13-strike call as well. This frenzy comes after the telehealth company's top-and bottom-line beat for the first quarter, which has shares up 5.9% to trade at $12.34 at last check.This preference for bullish bets is new. At theInternational Securities Exchange , Cboe Options Exchange , and NASDAQ OMX PHLX , the stock's 10-day put/call volume ratio sits higher than 94% of readings from the last 12 months, indicating puts have been more popular than usual in the last couple of weeks.Despite surging above the 40-day moving average right out of the gate, the security is now eyeing a close below this trendline, which emerged as resistance in early April. The $12 region is also enacting pressure. Nevertheless, HIMS amassed a 77.9% lead in th","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Rxj.CLyOZh1R6ikIwQVUHw--~B/aD00OTM7dz01MDc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/schaeffers_investment_research_24/52c46ced398508149729f9041e2d2899","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Rxj.CLyOZh1R6ikIwQVUHw--~B/aD00OTM7dz01MDc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/schaeffers_investment_research_24/52c46ced398508149729f9041e2d2899"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/telehealth-stock-gains-popularity-options-155457225.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433556205","title":"Social Buzz: Wallstreetbets Stocks Mostly Lower Pre-Bell Tuesday; Palantir to Decline, Hims & Hers Health to Advance","url":"https://stock-news.laohu8.com/highlight/detail?id=2433556205","media":"MT Newswires","top":-1,"share":"https://ttm.financial/m/news/2433556205?lang=en_us&edition=fundamental","pubTime":"2024-05-07 19:14","pubTimestamp":1715080491,"startTime":"0","endTime":"0","summary":"The most-talked-about stocks in the Reddit subforum Wallstreetbets were mostly lower hours before Tuesday's opening bell.Palantir Technologies  stock was 9.7% lower pre-bell, swinging from an 8.1% increase at Monday's close after the company's Q1 results showed a sharp sequential slowdown in US commercial revenue growth.Tesla  shares were down 1.9% premarket, reversing a 2% increase from the previous session. Tesla started another round of layoffs over the weekend with workers across several departments, including software, service and engineering receiving an email between Friday and Sunday, Electrek reported, citing sources familiar with the matter.Nvidia  stock was 1.4% lower hours before market open, offsetting a portion of its 3.8% increase from Monday's session.Walt Disney  shares were down 1.1% hours before the opening bell, reversing a part of their 2.5% increase from the previous session.Trump Media & Technology Group  shares were down 0.8% in pre-bell hours after closing Mond","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/social-buzz-wallstreetbets-stocks-mostly-111451399.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433222780","title":"BUZZ-Hims & Hers Health advances after raising FY forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2433222780","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2433222780?lang=en_us&edition=fundamental","pubTime":"2024-05-07 17:55","pubTimestamp":1715075752,"startTime":"0","endTime":"0","summary":"** Shares of healthcare services provider Hims & Hers Health  rise 15.62% to $13.47 premarket    ** Co raises FY rev and adj. EBITDA forecasts   ** Q1 rev also beats analysts estimates   ** Piper Sandler raises PT to $13 from $11, keeps \"neutral\" rating   ** Avg rating of 14 brokerages is \"buy\" and median PT is $16 -LSEG data   ** As of last close, stock had risen almost 31% YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433236652","title":"U.S. Stocks To Watch: Palantir, Lucid, Boeing, BP, Disney, Hims & Hers Health, and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2433236652","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2433236652?lang=en_us&edition=fundamental","pubTime":"2024-05-07 17:21","pubTimestamp":1715073689,"startTime":"0","endTime":"0","summary":"Stock futures were slipping Tuesday, with equities cooling off after a rally following a weaker-than-expected jobs report that boosted expectations of an interest-rate cut from the Federal Reserve this year.First-quarter losses at Lucid Group narrowed from a year earlier and sales at the electric-vehicle maker rose 21% to $173 million. Lucid produced 1,728 vehicles in the quarter, an increase of 40% from a year earlier, and said it still expects to make 9,000 units in 2024. The stock was down 8.2% in premarket trading. It closed Monday with a gain of 9.5%.Disney was up 0.6% ahead of the release of its fiscal second-quarter earnings before the stock market opens Tuesday. Analyst","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"gpt_icon":1},{"id":"2433258946","title":"Hims & Hers Health Shares Climb 11%, Expects To Hit 2025 Targets This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2433258946","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2433258946?lang=en_us&edition=fundamental","pubTime":"2024-05-07 06:24","pubTimestamp":1715034240,"startTime":"0","endTime":"0","summary":"Shares of Hims & Hers Health on Monday jumped 11% to $12.95 in post-market trading after the company said it expects to exceed its earnings and revenue outlook for 2025 a year early.The telehealth-consultation platform said its strengthened conviction about its 2025 targets comes as it expects to continue adding subscribers for its personalized solutions, which will also help it with improve its retention levels.\"Our strategy of equipping providers with high-quality, personalized solutions at mass market prices is a significant driving force behind our success,\" finance chief Yemi Okupe said on a call with analysts.In two years, the company has seen the number of subscribers that have opted for a personalized plan increase over six acts to north of 600,000 subscribers, Okupe added.Hims & Hers Health also said that it will also continue using marketing strategies to add subscribers and raise brand awareness, as marketing as a percentage of revenue improved more than 400 basis points in ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":1},{"id":"2433237078","title":"Hims & Hers Health Inc reports results for the quarter ended in March - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2433237078","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2433237078?lang=en_us&edition=fundamental","pubTime":"2024-05-07 06:05","pubTimestamp":1715033109,"startTime":"0","endTime":"0","summary":"* Hims & Hers Health Inc    reported quarterly adjusted earnings of 5 cents per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of -5 cents.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.1855},{"period":"1month","weight":0.1741},{"period":"3month","weight":0.4526},{"period":"6month","weight":0.9505},{"period":"1year","weight":0.4187},{"period":"ytd","weight":0.6371}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Oaktree Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the industrial and consumer sectors. The company was founded in 2019 and is based in Los Angeles, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.06333},{"month":2,"riseRate":0.6,"avgChangeRate":0.143326},{"month":3,"riseRate":0.4,"avgChangeRate":-0.00162},{"month":4,"riseRate":0.2,"avgChangeRate":-0.059815},{"month":5,"riseRate":0.4,"avgChangeRate":0.010815},{"month":6,"riseRate":0.75,"avgChangeRate":-0.011926},{"month":7,"riseRate":0.5,"avgChangeRate":0.014959},{"month":8,"riseRate":0.5,"avgChangeRate":-0.052701},{"month":9,"riseRate":0.25,"avgChangeRate":-0.0268},{"month":10,"riseRate":0.2,"avgChangeRate":-0.067321},{"month":11,"riseRate":0.8,"avgChangeRate":0.145964},{"month":12,"riseRate":0.6,"avgChangeRate":0.084497}],"exchange":"NYSE","name":"Hims & Hers Health Inc.","nameEN":"Hims & Hers Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hims & Hers Health Inc.(HIMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Hims & Hers Health Inc.(HIMS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Hims & Hers Health Inc.,HIMS,Hims & Hers Health Inc.股票,Hims & Hers Health Inc.股票老虎,Hims & Hers Health Inc.股票老虎国际,Hims & Hers Health Inc.行情,Hims & Hers Health Inc.股票行情,Hims & Hers Health Inc.股价,Hims & Hers Health Inc.股市,Hims & Hers Health Inc.股票价格,Hims & Hers Health Inc.股票交易,Hims & Hers Health Inc.股票购买,Hims & Hers Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hims & Hers Health Inc.(HIMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Hims & Hers Health Inc.(HIMS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}